ArticleOncogene2014

Targeting autophagy overcomes Enzalutamide resistance in castration-resistant prostate cancer cells and improves therapeutic response in a xenograft model.

H G Nguyen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.